Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Minervini

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Therapeutics and Clinical Risk Management|July 20, 2017
Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literatureNicola Sgherza, Elisabetta Abruzzese, Gianni Perla, et al.
Leukemia Research|May 26, 2004
Imatinib-mesylate for all patients with hypereosinophilic syndrome?Pellegrino Musto, Gianni Perla, Maria Marta Minervini, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 23, 2024
Isolated Right Ventricular Metastasis of Hepatocellular Carcinoma: Clinical Findings and Histopathology of an Atypical PresentationAaron Yee Shuen See, Pulkit Kasiviswanathan, Masood Pasha Syed, et al.
European Journal of Haematology|November 22, 2012
CD117-CD15 in acute myeloid leukemia: no role as LAIP in the study of minimal residual diseaseGiovanni Rossi, Josep Francesc Nomdedéu Guinot, Andrea Fontana, et al.
Hepatology (Baltimore, Md.)|October 22, 2021
Banff consensus recommendations for steatosis assessment in donor liversDesley A H Neil, Marta Minervini, Maxwell L Smith, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 1, 2022
Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic CholangiocarcinomaVenkata S Katabathina, Lokesh Khanna, Venkateswar R Surabhi, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|October 23, 2002
Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term studyNicola Cascavilla, Pellegrino Musto, Lorella Melillo, et al.
Leukemia Research|December 27, 2011
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targetsGiovanni Rossi, Maria Marta Minervini, Angelo Michele Carella, et al.
Annals of Hematology|February 21, 2014
Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm's tumor 1 levelsGiovanni Rossi, Maria Marta Minervini, Lorella Melillo, et al.
Cytometry. Part B, Clinical Cytometry|May 13, 2021
Log reduction of leukemic cells and minimal residual disease by flow cytometry represent effective predictors of clinical outcome in elderly patients with acute myeloid leukemiaGiovanni Rossi, Vincenzo Giambra, Chiara de Waure, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Therapeutics and Clinical Risk Management|July 20, 2017
Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literatureNicola Sgherza, Elisabetta Abruzzese, Gianni Perla, et al.
Leukemia Research|May 26, 2004
Imatinib-mesylate for all patients with hypereosinophilic syndrome?Pellegrino Musto, Gianni Perla, Maria Marta Minervini, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 23, 2024
Isolated Right Ventricular Metastasis of Hepatocellular Carcinoma: Clinical Findings and Histopathology of an Atypical PresentationAaron Yee Shuen See, Pulkit Kasiviswanathan, Masood Pasha Syed, et al.
European Journal of Haematology|November 22, 2012
CD117-CD15 in acute myeloid leukemia: no role as LAIP in the study of minimal residual diseaseGiovanni Rossi, Josep Francesc Nomdedéu Guinot, Andrea Fontana, et al.
Hepatology (Baltimore, Md.)|October 22, 2021
Banff consensus recommendations for steatosis assessment in donor liversDesley A H Neil, Marta Minervini, Maxwell L Smith, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 1, 2022
Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic CholangiocarcinomaVenkata S Katabathina, Lokesh Khanna, Venkateswar R Surabhi, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|October 23, 2002
Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term studyNicola Cascavilla, Pellegrino Musto, Lorella Melillo, et al.
Leukemia Research|December 27, 2011
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targetsGiovanni Rossi, Maria Marta Minervini, Angelo Michele Carella, et al.
Annals of Hematology|February 21, 2014
Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm's tumor 1 levelsGiovanni Rossi, Maria Marta Minervini, Lorella Melillo, et al.
Cytometry. Part B, Clinical Cytometry|May 13, 2021
Log reduction of leukemic cells and minimal residual disease by flow cytometry represent effective predictors of clinical outcome in elderly patients with acute myeloid leukemiaGiovanni Rossi, Vincenzo Giambra, Chiara de Waure, et al.
Pageof 3